MedTrace Logo

Multi-Center Pilot Study of truSculpt Device

NCT03433430 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2023-09-18

Study results available
· View outcomes & findings →

Summary

An exploratory pilot study to evaluate the safety, efficacy and ergonomics of Cutera truSculpt device

Conditions

  • Bulging
  • Body Fat

Interventions

DEVICE

truSculpt

Subjects will receive utreatments and will be followed at 12 weeks post final treatment.

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen Ronan, MD · Cutera Research Center

  • Ashish Bhatia, MD · The Dermatology Institute of DuPage Medical Group

  • Joely Kaufman, MD, FAAD · Skin Associates of South Florida

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-17
Primary Completion
2018-03-07
Completion
2018-03-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03433430 on ClinicalTrials.gov